1 Market Overview
1.1 Therapeutic Nuclear Medicines Introduction
1.2 Market Analysis by Type
1.2.1 Radium-223
1.2.2 Lutetium-177
1.2.3 Iodine-131
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 Thyroid
1.3.2 Bone Metastasis
1.3.3 Lymphoma
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2015-2025)
1.4.1.2 Canada Market States and Outlook (2015-2025)
1.4.1.3 Mexico Market States and Outlook (2015-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2015-2025)
1.4.2.2 France Market States and Outlook (2015-2025)
1.4.2.3 UK Market States and Outlook (2015-2025)
1.4.2.4 Russia Market States and Outlook (2015-2025)
1.4.2.5 Italy Market States and Outlook (2015-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2015-2025)
1.4.3.2 Japan Market States and Outlook (2015-2025)
1.4.3.3 Korea Market States and Outlook (2015-2025)
1.4.3.4 India Market States and Outlook (2015-2025)
1.4.3.5 Southeast Asia Market States and Outlook (2015-2025)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2015-2025)
1.4.4.2 Egypt Market States and Outlook (2015-2025)
1.4.4.3 Saudi Arabia Market States and Outlook (2015-2025)
1.4.4.4 South Africa Market States and Outlook (2015-2025)
1.4.4.5 Turkey Market States and Outlook (2015-2025)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Therapeutic Nuclear Medicines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.2 Novartis AG
2.2.1 Business Overview
2.2.2 Therapeutic Nuclear Medicines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis AG Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.3 China Isotope & Radiation
2.3.1 Business Overview
2.3.2 Therapeutic Nuclear Medicines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.4 Dongcheng
2.4.1 Business Overview
2.4.2 Therapeutic Nuclear Medicines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Dongcheng Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.5 Q BioMed
2.5.1 Business Overview
2.5.2 Therapeutic Nuclear Medicines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Q BioMed Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.6 Curium Pharmaceuticals
2.6.1 Business Overview
2.6.2 Therapeutic Nuclear Medicines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.7 Jubilant DraxImage
2.7.1 Business Overview
2.7.2 Therapeutic Nuclear Medicines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.8 Lantheus
2.8.1 Business Overview
2.8.2 Therapeutic Nuclear Medicines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.9 Spectrum Pharmaceuticals
2.9.1 Business Overview
2.9.2 Therapeutic Nuclear Medicines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.10 Progenics Pharmaceuticals
2.10.1 Business Overview
2.10.2 Therapeutic Nuclear Medicines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.11 International Isotopes
2.11.1 Business Overview
2.11.2 Therapeutic Nuclear Medicines Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
3 Global Therapeutic Nuclear Medicines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2019)
3.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Manufacturer (2017-2019)
3.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Manufacturer (2017-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Therapeutic Nuclear Medicines Manufacturer Market Share in 2019
3.3.2 Top 6 Therapeutic Nuclear Medicines Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Therapeutic Nuclear Medicines Market Analysis by Regions
4.1 Global Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Regions
4.1.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Regions (2015-2019)
4.1.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Regions (2015-2019)
4.2 North America Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
4.3 Europe Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
4.4 Asia-Pacific Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
4.5 South America Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
4.6 Middle East and Africa Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
5 North America Therapeutic Nuclear Medicines by Country
5.1 North America Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
5.1.1 North America Therapeutic Nuclear Medicines Sales and Market Share by Country (2015-2019)
5.1.2 North America Therapeutic Nuclear Medicines Revenue and Market Share by Country (2015-2019)
5.2 United States Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
5.3 Canada Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
5.4 Mexico Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
6 Europe Therapeutic Nuclear Medicines by Country
6.1 Europe Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
6.1.1 Europe Therapeutic Nuclear Medicines Sales and Market Share by Country (2015-2019)
6.1.2 Europe Therapeutic Nuclear Medicines Revenue and Market Share by Country (2015-2019)
6.2 Germany Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
6.3 UK Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
6.4 France Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
6.5 Russia Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
6.6 Italy Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
7 Asia-Pacific Therapeutic Nuclear Medicines by Country
7.1 Asia-Pacific Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Therapeutic Nuclear Medicines Sales and Market Share by Country (2015-2019)
7.1.2 Asia-Pacific Therapeutic Nuclear Medicines Revenue and Market Share by Country (2015-2019)
7.2 China Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
7.3 Japan Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
7.4 Korea Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
7.5 India Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
7.6 Southeast Asia Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
8 South America Therapeutic Nuclear Medicines by Country
8.1 South America Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
8.1.1 South America Therapeutic Nuclear Medicines Sales and Market Share by Country (2015-2019)
8.1.2 South America Therapeutic Nuclear Medicines Revenue and Market Share by Country (2015-2019)
8.2 Brazil Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
8.3 Argentina Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
8.4 Colombia Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
9 Middle East and Africa Therapeutic Nuclear Medicines by Countries
9.1 Middle East and Africa Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Therapeutic Nuclear Medicines Sales and Market Share by Country (2015-2019)
9.1.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue and Market Share by Country (2015-2019)
9.2 Saudi Arabia Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
9.3 Turkey Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
9.4 Egypt Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
9.5 Nigeria Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
9.6 South Africa Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2019)
10 Global Therapeutic Nuclear Medicines Market Segment by Type
10.1 Global Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Type (2015-2019)
10.1.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Type (2015-2019)
10.1.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2015-2019)
10.2 Radium-223 Sales Growth and Price
10.2.1 Global Radium-223 Sales Growth (2015-2019)
10.2.2 Global Radium-223 Price (2015-2019)
10.3 Lutetium-177 Sales Growth and Price
10.3.1 Global Lutetium-177 Sales Growth (2015-2019)
10.3.2 Global Lutetium-177 Price (2015-2019)
10.4 Iodine-131 Sales Growth and Price
10.4.1 Global Iodine-131 Sales Growth (2015-2019)
10.4.2 Global Iodine-131 Price (2015-2019)
10.5 Other Sales Growth and Price
10.5.1 Global Other Sales Growth (2015-2019)
10.5.2 Global Other Price (2015-2019)
11 Global Therapeutic Nuclear Medicines Market Segment by Application
11.1 Global Therapeutic Nuclear Medicines Sales Market Share by Application (2015-2019)
11.2 Thyroid Sales Growth (2015-2019)
11.3 Bone Metastasis Sales Growth (2015-2019)
11.4 Lymphoma Sales Growth (2015-2019)
11.5 Other Sales Growth (2015-2019)
12 Therapeutic Nuclear Medicines Market Forecast (2020-2025)
12.1 Global Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate (2020-2025)
12.2 Therapeutic Nuclear Medicines Market Forecast by Regions (2020-2025)
12.2.1 North America Therapeutic Nuclear Medicines Market Forecast (2020-2025)
12.2.2 Europe Therapeutic Nuclear Medicines Market Forecast (2020-2025)
12.2.3 Asia-Pacific Therapeutic Nuclear Medicines Market Forecast (2020-2025)
12.2.4 South America Therapeutic Nuclear Medicines Market Forecast (2020-2025)
12.2.5 Middle East and Africa Therapeutic Nuclear Medicines Market Forecast (2020-2025)
12.3 Therapeutic Nuclear Medicines Market Forecast by Type (2020-2025)
12.3.1 Global Therapeutic Nuclear Medicines Sales Forecast by Type (2020-2025)
12.3.2 Global Therapeutic Nuclear Medicines Market Share Forecast by Type (2020-2025)
12.4 Therapeutic Nuclear Medicines Market Forecast by Application (2020-2025)
12.4.1 Global Therapeutic Nuclear Medicines Sales Forecast by Application (2020-2025)
12.4.2 Global Therapeutic Nuclear Medicines Market Share Forecast by Application (2020-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
